| Quarterly Financials | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
Revenue  | 230 | 290 | 258 | 300 | 401 | 591 | 553 | 634 | 679 | 951 | 757 | 909 | 965 | 1,188 | 1,152 | 1,274 | 1,392 | 1,609 | 1,448 |
| Expenses | 234 | 339 | 356 | 491 | 685 | 795 | 740 | 800 | 744 | 937 | 743 | 901 | 898 | 1,085 | 1,050 | 1,175 | 1,264 | 1,395 | 1,314 |
| EBITDA | -4 | -49 | -98 | -191 | -284 | -204 | -187 | -166 | -65 | 14 | 14 | 8 | 67 | 103 | 102 | 99 | 128 | 214 | 135 |
| Operating Profit % | -10 % | -25 % | -50 % | -76 % | -86 % | -47 % | -46 % | -39 % | -22 % | -8 % | -12 % | -11 % | -3 % | 0 % | -4 % | -1 % | 2 % | 7 % | 3 % |
| Depreciation | 12 | 10 | 10 | 10 | 11 | 12 | 13 | 16 | 18 | 18 | 20 | 22 | 23 | 24 | 25 | 29 | 34 | 33 | 34 |
| Interest | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 6 | 6 | 6 | 6 | 7 | 6 | 7 | 6 | 9 | 9 | 9 | 9 |
| Profit Before Tax | -18 | -62 | -111 | -204 | -298 | -220 | -204 | -187 | -88 | -9 | -12 | -21 | 37 | 73 | 71 | 60 | 85 | 171 | 92 |
| Tax | 2 | 2 | 0 | 0 | 0 | -1 | -0 | 0 | 0 | 0 | 0 | -0 | 0 | 13 | 11 | 9 | 14 | 1 | 8 |
| Net Profit | -20 | -64 | -111 | -204 | -298 | -220 | -204 | -187 | -88 | -9 | -12 | -21 | 37 | 60 | 60 | 51 | 72 | 171 | 85 |
| EPS in ₹ | -0.52 | -2,823.94 | -2.91 | -5.26 | -7.00 | -4.99 | -4.62 | -4.19 | -1.96 | -0.20 | -0.26 | -0.45 | 0.85 | 1.35 | 1.34 | 1.12 | 1.57 | 3.73 | 1.85 |
PB FinTech
PB FinTech
1,829.40
+22.00
(1.22%)
There are 2 new updates from the company23 hours ago
View
Market Cap
84,016.53 Cr
EPS
7.77
PE Ratio
219.76
Dividend Yield
0.00 %
Industry
Financial Services52 Week High
2,246.90
52 Week Low
1,311.35
PB Ratio
12.90
Debt to Equity
0.04
Sector
Fintech
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from20 analysts
Company News
View All News
Outpatient Department coverage in health insurance has increased significantly, with 22% of policies now including OPD benefits compared to 5% three years ago, according to Policybazaar data. OPD cover extends beyond hospitalization to include doctor consultations, diagnostic tests, pharmacy expenses, dental treatment, and preventive check-ups, with 90% of claims processed cashlessly. Users with OPD coverage make claims 3-4 times annually and show 5-10% fewer hospitalizations. The 30-45 age group represents the largest adoption share at 33%, followed by 18-30 age group at 27%. Tier-1 cities account for half of OPD users, with Mumbai, Hyderabad, and Chennai showing highest uptake. Consultations comprise 35-40% of OPD claims, diagnostics 25-30%, and pharmacy purchases 20-25%. Tele-consultations now represent 45-50% of usage compared to 50-55% for physical visits. OPD sum insured limits have increased to ₹1 lakh, making coverage more relevant for frequent healthcare needs.
PB Fintech Ltd. witnessed a block trade on NSE involving approximately 200,262 shares valued at Rs. 36.10 crores. The shares were traded at a price of Rs. 1,802.70 per share.
GST Exemption on Insurance Products to Boost Market Awareness, Says PB Fintech CEO5 days ago
The GST Council exempted individual life and health insurance from 18% tax, which PB Fintech CEO Yashish Dahiya called a landmark reform. Dahiya emphasized the change is more about government messaging than pricing impact, as it signals these are essential products every family should consider. He noted that health and term insurance categories remain underpenetrated in India despite being critical for middle-class families. While the GST exemption won't dramatically alter Policybazaar's profitability, it will help expand the overall market by creating trust and recognition for essential insurance products. Dahiya explained that Policybazaar spends 85% of its advertising budget convincing consumers about insurance importance, and the government's move provides significant validation for their efforts.
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,829.40 | #1 84,016.53 | #1 219.76 | #2 4,977.21 | #4 35.55 | #1 353 | #3 41.17 | 46.96 | |
1,237.60 | 78,971.57 | - | #1 7,624.90 | -27.55 | -663 | 114.58 | 55.91 | |
16.07 | 4,482.72 | #1 21.14 | 4,065.70 | 57.36 | 236 | -15.97 | 53.27 | |
305.41 | 2,372.62 | 222.71 | 1,192.50 | 58.67 | -122 | -534.85 | 70.79 | |
54.55 | 680.12 | 60.28 | 620.40 | #1 76.03 | 14 | #1 125.81 | 61.09 | |
60.00 | 132.24 | - | 22.90 | -40.21 | -5 | 0.00 | 44.36 | |
4.12 | 86.44 | - | 10.62 | -73.72 | -17 | -7.50 | 43.42 | |
4.95 | 63.57 | 44.18 | 1,508.80 | -11.64 | -80 | -1,161.69 | 38.67 |
Automatic Screeners on ScanX
Forecast
Actual
Growth Rate
Revenue Growth
35.55 %
Net Income Growth
-113.20 %
Cash Flow Change
102.89 %
ROE
-112.36 %
ROCE
-120.66 %
EBITDA Margin (Avg.)
-135.62 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 880 | 751 | 1,576 | 2,331 | 5,916 | 6,254 | 6,729 | 7,529 |
| Fixed Assets | 11 | 119 | 147 | 125 | 205 | 313 | 359 | 417 |
| Current Assets | 810 | 540 | 1,311 | 2,140 | 5,572 | 4,122 | 4,823 | 3,853 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 650 | 125 | 2 | 138 | 373 | 622 | 1,359 | 0 |
| Other Assets | 219 | 507 | 1,427 | 2,068 | 5,338 | 5,319 | 5,011 | 0 |
| Total Liabilities | 880 | 751 | 1,576 | 2,331 | 5,916 | 6,254 | 6,729 | 7,529 |
| Current Liabilities | 85 | 187 | 203 | 221 | 337 | 551 | 603 | 751 |
| Non Current Liabilities | 7 | 74 | 107 | 118 | 166 | 218 | 249 | 340 |
| Total Equity | 788 | 490 | 1,266 | 1,992 | 5,412 | 5,485 | 5,877 | 6,432 |
| Reserve & Surplus | 787 | 489 | 1,265 | 1,991 | 5,322 | 5,386 | 5,781 | 6,340 |
| Share Capital | 1 | 1 | 1 | 1 | 90 | 90 | 90 | 92 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Net Cash Flow | 2 | -27 | -5 | 69 | 747 | -415 | -71 | -295 | 253 |
| Investing Activities | -15 | -244 | -434 | 375 | 79 | -1,202 | -2,125 | 46 | 301 |
| Operating Activities | -102 | -97 | -83 | -282 | -364 | 29 | -1,568 | -299 | 9 |
| Financing Activities | 119 | 315 | 513 | -23 | 1,031 | 759 | 3,621 | -43 | -57 |
Share Holding
| % Holding | Jul 2021 | Nov 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
| Promoter | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 22.21 % | 21.11 % | 14.50 % | 14.05 % | 7.62 % | 48.97 % | 51.58 % | 49.71 % | 47.79 % | 45.93 % | 46.78 % |
| DIIs | 0.00 % | 3.55 % | 3.03 % | 3.74 % | 3.03 % | 5.52 % | 14.95 % | 14.02 % | 15.41 % | 11.53 % | 14.13 % | 16.75 % | 16.27 % | 18.41 % | 20.57 % | 22.95 % | 23.27 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 0.00 % | 8.74 % | 7.05 % | 7.34 % | 7.29 % | 7.30 % | 7.51 % | 6.42 % | 6.06 % | 5.64 % | 5.65 % | 5.39 % | 4.74 % | 4.81 % | 4.66 % | 4.27 % | 4.30 % |
| Others | 100.00 % | 87.71 % | 89.92 % | 88.91 % | 89.68 % | 87.18 % | 55.33 % | 58.45 % | 64.03 % | 68.78 % | 72.60 % | 28.89 % | 27.41 % | 27.08 % | 26.98 % | 26.85 % | 25.64 % |
| No of Share Holders | 0 | 192 | 3,92,371 | 1,81,998 | 2,00,729 | 1,99,319 | 2,04,329 | 1,95,672 | 1,91,704 | 1,80,765 | 1,65,933 | 1,52,153 | 1,45,383 | 1,52,948 | 1,48,275 | 1,51,205 | 1,64,551 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 26 Sept 2025 |  Annual General Meeting | NA | 26 Sept 2025 | 1,822.70 | 1,806.40 |
| 30 Jun 2021 |  Change Of Name | NA | 30 Jun 2021 | 0.00 | 0.00 |
| 27 Sept 2024 | Annual General Meeting | NA | 27 Sept 2024 | 1,813.80 | 1,694.95 |
| 05 Nov 2024 |  Quarterly Result Announcement | NA | 05 Nov 2024 | 1,658.00 | 1,712.75 |
| 30 Jan 2025 | Quarterly Result Announcement | NA | 30 Jan 2025 | 1,813.25 | 1,713.00 |
| 15 May 2025 | Quarterly Result Announcement | NA | 15 May 2025 | 1,616.65 | 1,754.35 |
| 31 Jul 2025 | Quarterly Result Announcement | NA | 31 Jul 2025 | 1,794.50 | 1,822.40 |
Announcements
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
25 minutes ago
25 minutes agoReg. 34 (1) Annual Report.22 hours ago
22 hours agoBusiness Responsibility and Sustainability Reporting (BRSR)23 hours ago
23 hours agoAnnouncement under Regulation 30 (LODR)-Newspaper Publication5 days ago
5 days agoDispatch Of Physical Communication To Shareholders For Notice And Annual Report5 days ago
5 days agoBusiness Responsibility and Sustainability Reporting (BRSR)6 days ago
6 days agoReg. 34 (1) Annual Report.6 days ago
6 days agoNotice Of 17Th Annual General Meeting6 days ago
6 days agoAnnouncement under Regulation 30 (LODR)-Newspaper Publication6 days ago
6 days agoDisclosure Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015Aug 29, 2025
Aug 29, 2025Announcement under Regulation 30 (LODR)-Change in DirectorateAug 27, 2025
Aug 27, 2025Grants Of Stock Options Under PB Fintech Employees Stock Option Plan 2021Aug 26, 2025
Aug 26, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 22, 2025
Aug 22, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 07, 2025
Aug 07, 2025Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations 2015Aug 05, 2025
Aug 05, 2025Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015Aug 02, 2025
Aug 02, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 02, 2025
Aug 02, 2025Announcement under Regulation 30 (LODR)-Monitoring Agency ReportAug 01, 2025
Aug 01, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 01, 2025
Aug 01, 2025Financial Results For The Quarter Ended June 30 2025Jul 31, 2025
Jul 31, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On Thursday July 31 2025Jul 31, 2025
Jul 31, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 24, 2025
Jul 24, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 23, 2025
Jul 23, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 21, 2025
Jul 21, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 18, 2025
Jul 18, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 14, 2025
Jul 14, 2025Board Meeting Intimation for Approval Of Unaudited Financials Results For Q1FY26 (Standalone & Consolidated)Jul 14, 2025
Jul 14, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 14, 2025
Jul 14, 2025Update On Incorporation Of A Step Down Subsidiary In DubaiJul 09, 2025
Jul 09, 2025Closure of Trading WindowJun 30, 2025
Jun 30, 2025Closure of Trading WindowJun 27, 2025
Jun 27, 2025Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 - Updates On InvestmentJun 27, 2025
Jun 27, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 29, 2025
May 29, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 22, 2025
May 22, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 22, 2025
May 22, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 17, 2025
May 17, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 16, 2025
May 16, 2025Announcement under Regulation 30 (LODR)-Monitoring Agency ReportMay 15, 2025
May 15, 2025Financial Results For The Quarter And Year Ended March 31 2025May 15, 2025
May 15, 2025Board Meeting Outcome for Outcome Of The Board Meeting Held On Thursday May 15 2025May 15, 2025
May 15, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 15, 2025
May 15, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 13, 2025
May 13, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 09, 2025
May 09, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 08, 2025
May 08, 2025Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015May 03, 2025
May 03, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 02, 2025
May 02, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 01, 2025
May 01, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationApr 30, 2025
Apr 30, 2025Board Meeting Intimation for Board Meeting Under Regulation 29 Of The SEBI (Listing Obligation And Disclosure Requirement) Regulations 2015 And Update On Closure Of Trading WindowApr 29, 2025
Apr 29, 2025Disclosure Under Regulation 30 Of The SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 - Investment In PB Healthcare Services Private LimitedApr 24, 2025
Apr 24, 2025Technical Indicators
RSI(14)
Neutral 46.96
ATR(14)
Less Volatile 58.05
STOCH(9,6)
Neutral 31.69
STOCH RSI(14)
Neutral 23.98
MACD(12,26)
Bearish -6.76
ADX(14)
Weak Trend 17.86
UO(9)
Bearish 37.60
ROC(12)
Downtrend But Slowing Down -5.27
WillR(14)
Neutral -77.52
Mutual Fund Holdings
HDFC Mid Cap Fund Direct-Growth 
Mirae Asset Large & Midcap Fund Direct-Growth 
Kotak Arbitrage Fund Direct-Growth 
Franklin India Focused Equity Fund Direct-Growth 
Edelweiss Mid Cap Direct Plan-Growth 
Tata Digital India Fund Direct-Growth 
Sundaram Mid Cap Fund Direct-Growth 
HSBC Midcap Fund Direct-Growth 
Canara Robeco Large Cap Fund Direct-Growth 
Axis Large & Mid Cap Fund Direct-Growth 
PGIM India Midcap Fund Direct-Growth 
HDFC Innovation Fund Direct-Growth 
Invesco India Arbitrage Fund Direct-Growth 
SBI Innovative Opportunities Fund Direct-Growth About PB FinTech
PB Fintech Limited, formerly Etechaces Marketing and Consulting Private Limited, is an Indian company providing online marketing and IT consulting services for the financial services industry, particularly insurance. It operates Policybazaar, India's largest digital insurance marketplace, and Paisabazaar, a platform for lending products. The company expanded to the United Arab Emirates in 2018 through its subsidiary PB Fintech FZ-LLC. In 2021, PB Fintech Limited became publicly listed on the BSE and NSE. The company's services include insurance brokerage, online marketing, and support for various financial products. Its platforms, Policybazaar and Paisabazaar, cater to consumers with diverse financial needs, offering insurance and personal credit products respectively.
Listing Date
15 Nov, 2021(3 Years,
26 days)
Website
Chairperson NameYashish Dahiya
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
